The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance

ABSTRACT The resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by changes in legal frameworks, public attitudes, and an influx of venture capital (VC). This article explores the interplay between scientific innovation and capital investment within the psychedelic sector, highlighting how private funding shapes the form of research and its financialization. The study investigates the roles of VC and private interests in driving the psychedelic renaissance, examining how these financial forces influence ethical considerations and broader socio‐political implications. Through in‐depth interviews with key stakeholders in the industry, including in‐house scientists and investors, the research uncovers how market‐driven imperatives and financial conflicts of interest shape both scientific practices and public perceptions of psychedelic medicine—and how these perceptions, in turn, influence the industry. The analysis underscores the tension between the idealistic and capitalist narratives surrounding psychedelic medicine, suggesting that the psychedelic industry reflects broader trends in biotech and pharmaceutical industries, where innovation is closely tied to financial investment and market dynamics. At the same time, it highlights the paradox of psychedelic mysticism, which remains elusive to the rigid criteria of evidence‐based medicine, thereby challenging the prevailing paradigm of psychopharmacological research. The findings call for a critical examination, through continuous public engagement, of the ethical dimensions of integrating psychedelics into mainstream medicine, highlighting the need to focus on the emergence of grey areas within capital networks where cultural and political values are constantly rearranged and restructured.

Authors

Institutions

Publication Details

Journal
Future Humanities
Published
2024-12-26
DOI
https://doi.org/10.1002/fhu2.70004
Citations
5
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
3.20

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance

Minsu Yoo, Sofia Sakopoulos
5 citations
Future Humanities
Psychedelics and Drug Studies
3.20
article

The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance

Minsu Yoo, Sofia Sakopoulos
article en
5 citations

Abstract

ABSTRACT The resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by changes in legal frameworks, public attitudes, and an influx of venture capital (VC). This article explores the interplay between scientific innovation and capital investment within the psychedelic sector, highlighting how private funding shapes the form of research and its financialization. The study investigates the roles of VC and private interests in driving the psychedelic renaissance, examining how these financial forces influence ethical considerations and broader socio‐political implications. Through in‐depth interviews with key stakeholders in the industry, including in‐house scientists and investors, the research uncovers how market‐driven imperatives and financial conflicts of interest shape both scientific practices and public perceptions of psychedelic medicine—and how these perceptions, in turn, influence the industry. The analysis underscores the tension between the idealistic and capitalist narratives surrounding psychedelic medicine, suggesting that the psychedelic industry reflects broader trends in biotech and pharmaceutical industries, where innovation is closely tied to financial investment and market dynamics. At the same time, it highlights the paradox of psychedelic mysticism, which remains elusive to the rigid criteria of evidence‐based medicine, thereby challenging the prevailing paradigm of psychopharmacological research. The findings call for a critical examination, through continuous public engagement, of the ethical dimensions of integrating psychedelics into mainstream medicine, highlighting the need to focus on the emergence of grey areas within capital networks where cultural and political values are constantly rearranged and restructured.

Future HumanitiesVol. 3(1)
The New School (US)
Bundesministerium für Bildung und Forschung, RWTH Aachen University
Industry, innovation and infrastructure
Openalex Percentile: Top 8%
Psychedelics and Drug Studies
3.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.